欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IS/H/0477/001
药品名称Teriflunomide Adalvo
活性成分
    • teriflunomide 14.0 mg
剂型Film-coated tablet
上市许可持有人Adalvo Limited Malta Life Science Park, Level 1, Building 4, Sir Temi Zammit Buildings, San Gwann, SGN 3000, Malta
参考成员国 - 产品名称Iceland (IS)
Teriflunomide AdAlvo
互认成员国 - 产品名称
    • Finland (FI)
许可日期2022/09/21
最近更新日期2024/04/22
药物ATC编码
    • L04AA31 teriflunomide
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase